SLC32A1: Solute Carrier Family 32 Member 1 (VGAT)

The vesicular GABA and glycine transporter essential for inhibitory neurotransmission

Gene Information Card

Symbol SLC32A1
Full Name Solute Carrier Family 32 Member 1
Gene Type Protein coding
Chromosomal Location 20q11.23
NCBI Gene ID 140679 ncbi.nlm.nih.gov/gene/140679
Ensembl ID ENSG00000101438
UniProt ID Q9H598
OMIM ID 616440
HGNC ID 11018
Aliases VGAT, VIAAT, bA121O18.1

Description

SLC32A1 (Solute Carrier Family 32 Member 1), also known as VGAT (vesicular GABA transporter) or VIAAT (vesicular inhibitory amino acid transporter), is a transmembrane protein that transports GABA and glycine from the cytoplasm into synaptic vesicles. This loading is essential for inhibitory neurotransmission in the central nervous system. The protein is a member of the SLC32 family and uses a proton gradient generated by V-ATPase to drive neurotransmitter uptake. Loss-of-function mutations in SLC32A1 are associated with epilepsy, hyperekplexia, and other neurological disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Epileptic encephalopathy, early infantile, 79 (EIEE79) Loss-of-function mutations impair GABA/glycine vesicular loading, reducing inhibitory neurotransmission and causing hyperexcitability ClinVar, OMIM
Hyperekplexia 4 (HKPX4) Dominant-negative or loss-of-function variants disrupt transporter activity, leading to exaggerated startle responses and stiffness OMIM
Developmental and epileptic encephalopathy (DEE) Heterozygous missense mutations reduce transporter expression or function, contributing to seizure phenotypes ClinVar, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 High
Cerebral cortex 15.2 High
Cerebellum 10.8 High
Spinal cord 8.3 Medium
Retina 6.1 Medium
Testis 0.5 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 9.8 High expression in neuronal models
U-87 MG (glioblastoma) 2.1 Low expression
HEK293 (embryonic kidney) 0.3 Not expressed endogenously
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.539G>A (p.Arg180His) Missense Rare Reduced transporter activity; associated with EIEE79
c.1006C>T (p.Arg336Trp) Missense Rare Dominant-negative effect; linked to hyperekplexia
c.1123G>A (p.Gly375Arg) Missense Rare Loss of function; reported in DEE
c.1A>G (p.Met1?) Start loss Very rare Complete loss of protein; severe phenotype
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg180His) reduce or abolish GABA/glycine transport, leading to decreased inhibitory vesicle filling.

Gain of Function (GOF)

No gain-of-function mutations have been reported for SLC32A1.

Dominant Negative (DN)

p.Arg336Trp exerts a dominant-negative effect, likely by disrupting oligomerization or trafficking of the transporter.

Pathways

Neurotransmitter release cycle (R-HSA-112310)
Transmission across Chemical Synapses (R-HSA-112315)
GABAergic synapse (KEGG:04727)
Synaptic vesicle cycle (KEGG:04721)

Protein Summary

SLC32A1 encodes a 525-amino acid integral membrane protein with 10 transmembrane domains. It functions as a proton-coupled antiporter that exchanges luminal H+ for cytoplasmic GABA or glycine, accumulating these neurotransmitters in synaptic vesicles. The protein is highly expressed in inhibitory neurons and is essential for normal inhibitory neurotransmission. Structural studies show that the transporter adopts an inward-open conformation for substrate binding and an occluded state during transport. Mutations that disrupt its function lead to reduced inhibitory tone and are causative for several neurological disorders.

Related Products

Product name Cat.No. Species Gene ID
SLC32A1 Knockout HEK293 Cell Line EDJ-KQ9792 Human 140679 Details Get a Quote
SLC32A1 Knockout HeLa Cell Line EDJ-KQ58442 Human 140679 Details Get a Quote
SLC32A1 Knockout A-549 Cell Line EDJ-KQ66929 Human 140679 Details Get a Quote
SLC32A1 Knockout HCT 116 Cell Line EDJ-KQ75333 Human 140679 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: